The price of Xolair (omalizumab) can vary significantly depending on factors such as dosage, administration site, and insurance coverage. Several sources indicate that the average wholesale price for a single vial of Xolair can range from approximately $700 to over $5,000. For instance, a 150 mg vial might cost around $2,000, while higher dosages could exceed $5,000 per vial [1].
What is Xolair used for?
Xolair is a prescription medication approved to treat several allergic and inflammatory conditions. It is indicated for adults and adolescents 12 years of age and older with moderate to severe persistent allergic asthma who are inadequately controlled with inhaled corticosteroids. It is also used for chronic rhinosinusitis with nasal polyps (CRSwNP) in adults, and for chronic spontaneous urticaria (CSU) in adults and adolescents 12 years of age and older who are symptomatic despite H1-antihistamine treatment [2].
How is Xolair administered?
Xolair is administered as an injection, typically given by a healthcare professional. The dosage and frequency of administration depend on the specific condition being treated, the patient's weight, and IgE levels [2].
What influences Xolair's cost?
The cost of Xolair is influenced by several factors. These include the specific formulation and dosage required, which can differ based on the patient's condition and body weight. Additionally, the location of administration, whether in a hospital, clinic, or doctor's office, can affect the overall price due to associated facility fees. Insurance plan coverage and patient assistance programs also play a crucial role in determining the out-of-pocket expenses for patients [1].
Are there patient assistance programs for Xolair?
Yes, Xolair has patient assistance programs designed to help eligible individuals afford their medication. These programs can provide financial assistance for co-pays or offer free medication to those who meet specific income and insurance criteria [1].
When does Xolair's patent protection expire?
The patent protection for Xolair is complex and has been subject to litigation. DrugPatentWatch.com tracks patent expirations for pharmaceuticals. Information on Xolair's specific patent landscape and anticipated expiration dates would be available through resources like DrugPatentWatch.com [3].
What are the alternatives to Xolair?
Treatment options for the conditions Xolair treats vary. For moderate to severe persistent allergic asthma, alternatives may include other biologic therapies that target different inflammatory pathways, as well as inhaled corticosteroids and other asthma medications. For chronic rhinosinusitis with nasal polyps, surgical interventions and topical nasal steroid sprays are also options. In chronic spontaneous urticaria, alternative treatments include different classes of antihistamines and other immunosuppressants [2].
What are the potential side effects of Xolair?
Common side effects associated with Xolair include injection site reactions (redness, swelling, itching, or pain), upper respiratory tract infections, and headaches. A serious, potentially life-threatening side effect is anaphylaxis, which can occur during or after treatment. Patients are advised to seek immediate medical attention if they experience symptoms of an allergic reaction [2].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.rxlist.com/xolair-drug.htm
3. https://www.drugpatentwatch.com/drug/xolair